Pharmaceutical Administration and Regulations in Japan - Nihs
Pharmaceutical Administration and Regulations in Japan - Nihs
Pharmaceutical Administration and Regulations in Japan - Nihs
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(4) On-site surveys for accreditation of<br />
overseas manufacturers<br />
When a GMP compliance survey is<br />
performed simultaneously with the<br />
accreditation, the structures <strong>and</strong><br />
facilities are required for accreditation<br />
to be confirmed <strong>in</strong> the GMP<br />
compliance survey, as a rule.<br />
3.8 Drug Retail Seller Licens<strong>in</strong>g<br />
A license must be obta<strong>in</strong>ed from the<br />
Prefectural Governor or other specified<br />
officials for market<strong>in</strong>g or otherwise provid<strong>in</strong>g<br />
of drugs. Licenses for drug retailers have<br />
been classified as follows based on<br />
amendment of the <strong>Pharmaceutical</strong> Affairs<br />
Law enacted on June 14, 2006 (Law No. 69:<br />
enforced from June 1, 2009). :<br />
(1) Pharmacies<br />
(2) Store-based drug sellers<br />
(3) Drug sellers by household<br />
distribution<br />
(4) Drug sellers by wholesale<br />
distribution<br />
* For store-based drug sellers <strong>and</strong><br />
drug sellers by household<br />
distribution, qualifications<br />
(prefectural exam<strong>in</strong>ation) for newly<br />
registered sellers have been<br />
established <strong>in</strong> addition to the those<br />
for pharmacists. These sellers can<br />
market drugs except for type 1<br />
drugs.<br />
<strong>Pharmaceutical</strong> <strong>Regulations</strong> <strong>in</strong> <strong>Japan</strong>:<br />
3.9 Quality St<strong>and</strong>ards <strong>and</strong> Government<br />
Certification<br />
The <strong>Japan</strong>ese Pharmacopoeia, <strong>Japan</strong>ese<br />
<strong>Pharmaceutical</strong> Codex, <strong>Japan</strong>ese<br />
<strong>Pharmaceutical</strong> Excipients, <strong>and</strong> other similar<br />
st<strong>and</strong>ards have been specified as quality<br />
st<strong>and</strong>ards. Certa<strong>in</strong> specified drugs such as<br />
biological products must not be marketed or<br />
supplied without government certification<br />
based on batch tests.<br />
3.10 Label<strong>in</strong>g <strong>and</strong> Package Inserts<br />
Specified items must be entered on the<br />
immediate conta<strong>in</strong>er of drugs. The package<br />
<strong>in</strong>serts must conta<strong>in</strong> <strong>in</strong>dications,<br />
dosage/adm<strong>in</strong>istration, precautions, <strong>and</strong><br />
precautions for h<strong>and</strong>l<strong>in</strong>g.<br />
All <strong>in</strong>gredients used as excipients must be<br />
<strong>in</strong>cluded <strong>in</strong> the package <strong>in</strong>serts of<br />
prescription <strong>and</strong> non-prescription drugs.<br />
Entries <strong>in</strong> the package <strong>in</strong>serts of biological<br />
products are specified <strong>in</strong> Notification No.<br />
0515005 of the PFSB dated May 15, 2003<br />
<strong>and</strong> label<strong>in</strong>g on the immediate conta<strong>in</strong>er or<br />
packag<strong>in</strong>g of biological products is specified<br />
<strong>in</strong> Notification No. 0515017 of the PFSB<br />
dated May 15, 2003. These specifications<br />
came <strong>in</strong>to effect from July 30, 2003.<br />
Accord<strong>in</strong>g to the <strong>Pharmaceutical</strong> Affairs Law<br />
amended on April 1, 2005, a new regulatory<br />
category for prescription drug label<strong>in</strong>g<br />
2011-3 - 28 -